Samnyte Tattoo Numbing Creams Recall

Published by Reclia Safety Desk | July 20, 2026

Recall Information Record: Samnyte Tattoo Numbing Creams

1. Recall Summary
On December 15, 2022, a recall was announced for Samnyte Tattoo Numbing Creams. The recall was initiated because the product’s packaging does not meet the child-resistant packaging requirements mandated by the Poison Prevention Packaging Act. The product contains lidocaine, which poses a risk of poisoning to young children if ingested. The recall was issued by the U.S. Consumer Product Safety Commission (CPSC) under Recall Number 23070. The product was imported by Liu Xianli (Amazon Storefront: Tattoo Castle USA), of Staten Island, New York, and manufactured by Sainite Trading (Shenzhen) Co. LTD, of China. No injuries have been reported in connection with this recall.

2. Affected Products
The recall involves Samnyte Tattoo Numbing Cream sold in 60ml tubes. The product contains Lidocaine 5% with Vitamin E. The cream is packaged in a white tube with a flip-top closure. The drug facts label is located on the back of the tube. The product was sold exclusively online at www.amazon.com from April 2022 through October 2022 for approximately $23. Approximately 9,000 units were sold in the United States. The specific model number or UPC is not specified in the recall notice.

3. Hazard Information
The hazard identified in the recall notice is that the packaging of the tattoo numbing cream is not child resistant as required by the Poison Prevention Packaging Act. Because the cream contains lidocaine, there is a risk of poisoning to young children if they ingest the product. No incidents or injuries have been reported to date. The recall notice does not provide any additional hazard details beyond this specific packaging and poisoning risk.

4. Consumer Action Required
Consumers who have purchased the recalled Samnyte Tattoo Numbing Cream are instructed to take the following actions immediately:
– Stop using the recalled cream.
– Store the product in a location that is out of reach of children.
– Contact Liu Xianli for instructions on how to properly dispose of the product.

The recall notice states that Liu Xianli is contacting all known purchasers directly. Consumers are advised to follow the disposal instructions provided by the importer to ensure safe handling of the lidocaine-containing product.

5. Official Remedy
The official remedy for this recall is a full refund. Consumers who contact Liu Xianli and follow the provided disposal instructions will receive a full refund for the recalled product. The recall notice also lists “Replace” as a remedy option, but the primary instruction directs consumers to dispose of the product to receive a refund. No further details on the replacement option are provided in the recall notice.

6. Contact Information
Consumers can contact Liu Xianli using the following methods:
– Email: auoorhealth@outlook.com
– Online recall information page: http://mz6.cn/6lfCv7
– Company website: www.samnyte.xyz (click on “RECALL” for more information)

The recall notice does not provide a telephone number or physical mailing address for consumer inquiries. All known purchasers are being contacted directly by Liu Xianli. For additional information, consumers may also refer to the CPSC recall notice at the URL provided in the source data.

Frequently Asked Questions